Literature DB >> 11760032

Primary vitrectomy for the management of rhegmatogenous retinal detachment associated with choroidal detachment.

H H Ghoraba1.   

Abstract

PURPOSE: To evaluate the role and the results of primary vitrectomy in treating cases with coexisting rhegmatogenous retinal detachment and choroidal detachment.
METHODS: Eleven consecutive eyes with coexisting rhegmatogenous retinal detachment and choroidal detachment with proliferative vitreoretinopathy less than grade C were included. Release of traction on the breaks was achieved by vitrectomy and augmented by episcleral buckle if needed. Perfluorocarbon liquids were used to drain the subretinal fluid through the vitrectomy sclerotomies. The breaks were treated by endolaser under perfluorocarbon liquids. Postoperative tamponade was done by C3F8 gas or silicone oil. Cases were followed up for at least 3 months.
RESULTS: Retinal reattachment could be achieved and maintained in all cases by one or more surgeries. No recurrence of choroidal detachment has occurred. In each case, choroidal detachment was drained through the sclerotomies and retinal detachment was repaired.
CONCLUSION: Primary vitrectomy represents an effective line in the management of rhegmatogenous retinal detachment with coexisting choroidal detachment in phakic or nonphakic eyes.
SUMMARY: Primary vitrectomy is recommended for the management of choroidal detachment associated with retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11760032     DOI: 10.1007/s004170100345

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  The effect of single periocular injection of methylprednisolone and drainage of suprachoroidal fluid in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment.

Authors:  Yong Wei; RongLe Zhou; Xiaobo Wang; Xiuju Chen; Hao Chen
Journal:  Eye (Lond)       Date:  2019-04-02       Impact factor: 3.775

2.  Vitrectomy, lensectomy and silicone oil tamponade in the management of retinal detachment associated with choroidal detachment.

Authors:  Jun-Min Gui; Li Jia; Lei Liu; Jian-Di Liu
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

3.  Two-staged surgery as an alternative to buckle-vitrectomy for rhegmatogenous retinal detachment complicated by choroidal detachment.

Authors:  Naresh Babu; Piyush Kohli; Karthik Kumar; Renu P Rajan; Girish Baliga; Sagnik Sen; N O Ramachandran; S Bhavani; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2020-08-28       Impact factor: 2.031

4.  Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.

Authors:  Ying Dai; Zhifeng Wu; Huiming Sheng; Zhengwei Zhang; Mengxi Yu; Qing Zhang
Journal:  Mol Vis       Date:  2015-04-10       Impact factor: 2.367

5.  Ciliary body thickness changes after preoperative anti-inflammatory treatment in rhegmatogenous retinal detachment complicated by choroidal detachment.

Authors:  Yassine Alibet; Galyna Levytska; Nicolay Umanets; Natalya Pasyechnikova; Paul B Henrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-10       Impact factor: 3.117

6.  Outcomes of 23-gauge pars plana vitrectomy combined with phacoemulsification and capsulotomy without intraocular lens implantation in rhegmatogenous retinal detachment associated with choroidal detachment.

Authors:  Huiyan Xu; David Lutrin; Zhifeng Wu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Risk Factors of Recurrent Retinal Detachment Following Surgical Treatment for Rhegmatogenous Retinal Detachment: A Retrospective Study.

Authors:  Li-Yun Jia; Yan-Xia Sun; Yong-Peng Zhang; Kai Ma
Journal:  Risk Manag Healthc Policy       Date:  2020-12-30

8.  Macular hole as a risk factor of choroidal detachment in rhegmatogenous retinal detachment.

Authors:  Jae Hoon Kang; Kyung Ah Park; Woo Jae Shin; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2008-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.